Celltrion chairman says Phase 2 clinical trial for COVID antibody treatment are “wrapping up”

Celltrion Chairman Seo Jung-jin announced that Phase 2 clinical trials for his company’s COVID-19 antibody treatment are “wrapping up” and that “procedures for emergency use authorization with the Min

from 한겨레